TCI Technologies
At TCI, innovation is at the core of our mission. We continuously push the boundaries of scientific discovery and technological advancement to develop groundbreaking solutions in health, nutrition, and beauty. Our innovation framework spans multiple dimensions, ensuring excellence in raw materials, formulation science, and technical applications. By integrating cutting-edge research with sustainable practices, we aim to deliver superior products that enhance well-being and improve lives.
IBD Ingredients | From Biological Resource Discovery to Product Development
IBD (Integrated Bioscience Design) is TCI's consumer-needs-driven approach to ingredient innovation, integrating biological resource discovery, cross-disciplinary research, and product development capabilities to develop distinctive ingredients with product application potential.
TCI has developed more than 200 IBD ingredients, including botanical extracts, microbial fermentation ingredients, probiotics, specialty proteins, and rare plant stem cell-derived materials. Brands can evaluate suitable ingredient combinations according to product positioning, target-market requirements, dosage-form needs, and regulatory considerations for dietary supplements, functional beverages, beauty nutrition, and skincare products.
Botanical Extracts
Distinctive components explored from different plant parts and natural resources, providing diverse directions for product development.
Fermentation Ingredients and Probiotics
Microbial research and fermentation technology supporting product concepts for digestive wellness, daily nutrition, and broader health applications.
Specialty Proteins and Biotechnology Ingredients
Protein-based, bioactive, and biotechnology-derived ingredients supporting beauty nutrition, daily wellness, and differentiated product design.
Explore IBD Ingredients by Product Direction
Beauty Nutrition
Beauty-from-within, beauty nutrition, and skin wellness product concepts.
Digestive Wellness and Probiotics
Product directions related to daily digestive wellness, gut health, and microbiome research.
Metabolic Wellness and Dietary Fiber
Product concepts related to dietary management, satiety support, and daily metabolic wellness.
Sleep and Relaxation
Product directions for evening wellness, relaxation, and circadian rhythm-related concepts.
Immune and Daily Wellness
Daily nutrition and wellness-maintenance product concepts.
Women's and Men's Wellness
Product directions designed around different consumer groups and life stages.
Daily Wellness
Product concepts focused on long-term wellness maintenance and quality of life.
Customized Product Development
Integrated evaluation based on target market, dosage form, consumer insights, and brand positioning.
How Are IBD Ingredients Different from TCI Innovation Technologies?
IBD ingredients are specific materials that can be incorporated into finished product formulations. Synergene® formulation technology, doubleNUTRI® liposomal technology, and LipoMask® micro-particle mask technology are TCI's innovation technologies for formulation, delivery, or skincare applications. They can be used together with IBD ingredients, but they serve different roles in product development.
Actual ingredient suitability, recommended use level, dosage-form compatibility, regulatory status, and finished-product claims should be further confirmed according to the target market, complete formulation, and TCI's official technical documentation.
Biomedicine Research Center
The Biomedicine Research Center focuses on advancing biotechnology, pharmaceutical research, and regenerative medicine. Using our proprietary Bio-Resource Data Mining technology, we integrate bioinformatics and information science through AI-driven management platforms and cloud-based systems.
This data-driven approach significantly accelerates research and development by up to 70× while maintaining rigorous scientific standards. Each ingredient undergoes an average of more than 17,700 validation trials to ensure safety, performance, and reliability.
Genomics Research Center
This data-driven approach significantly accelerates research and development by up to 70× while maintaining rigorous scientific standards. Each ingredient undergoes an average of more than 17,700 validation trials to ensure safety, performance, and reliability.
TCI Group conducts research on a global scale to advance scientific understanding of ingredients, manufacturing innovations, and delivery systems. This research is supported through strategic collaborations with research-intensive medical institutions, academic universities, and selected contract research organizations. For clinical trials, TCI generally caps indirect costs at 15%, thereby facilitating the execution of sequential studies by participating institutions within the constraints of TCI's annual research budget.
FAQ
IBD ingredients are distinctive materials developed by TCI through IBD (Integrated Bioscience Design). Starting from consumer needs, IBD integrates biological resource discovery, cross-disciplinary research, and product development capabilities to help brands evaluate ingredients that can be incorporated into finished product formulations.
TCI has developed more than 200 IBD ingredients. Actual ingredient availability, specifications, market suitability, and product development conditions should be confirmed through TCI’s official technical documentation and project-specific evaluation.
TCI’s IBD portfolio includes botanical extracts, microbial fermentation ingredients, probiotics, specialty proteins, algae, and other biotechnology-derived materials. Individual ingredients differ in source, compositional characteristics, dosage-form compatibility, and regulatory suitability.
Brands can evaluate TCI IBD ingredients for beauty nutrition, digestive wellness and probiotics, metabolic and weight management, sleep and relaxation, immune and daily wellness, women’s and men’s wellness, and healthy aging product directions. Final product claims should be determined according to the complete formulation, available substantiation, and target-market regulations.
Listing a product direction only means ingredients can be evaluated for development in that direction; it does not mean the related efficacy has been substantiated.
In addition to ingredient source and specification information, IBD ingredients draw on TCI’s experience in biological resource discovery, product application, and formulation development. Brands should still assess whether each ingredient is suitable according to product positioning, target market, dosage-form needs, and regulatory requirements.
IBD ingredients are specific materials that can be incorporated into finished product formulations. Synergene® formulation technology, doubleNUTRI® liposomal technology, and LipoMask® micro-particle mask technology are TCI innovation technologies for formulation, delivery, or skincare applications. They can be used together with IBD ingredients but serve different roles in product development.
Depending on their characteristics and product positioning, TCI IBD ingredients may be evaluated for dietary supplements, functional beverages, beauty nutrition, and skincare products. Actual dosage forms, use levels, processing conditions, sensory performance, and storage stability should be confirmed through formulation trials, stability testing, and manufacturing validation.
Not every IBD ingredient is suitable for every product type or dosage form; applicable formats and use levels must be confirmed per project.
Brands should first identify the target consumer, product positioning, target market, intended dosage form, and communication direction. TCI can then conduct an integrated evaluation based on ingredient characteristics, formulation compatibility, sensory design, regulatory considerations, and manufacturing feasibility.
Yes. Depending on product positioning, IBD ingredients may be evaluated with vitamins, minerals, dietary fiber, proteins, botanical ingredients, or other food and nutrition ingredients. The final formulation should confirm ingredient compatibility, sensory performance, stability, regulatory suitability, and product claims.
Whether a specific combination and use level is workable must be confirmed through formulation trials and production validation; no combination is validated here.
TCI can provide relevant specifications, source information, analytical data, and technical documentation according to product development needs. Available documents and test items may differ according to ingredient type, target market, and project requirements.
The documents and test items that can actually be supplied must be confirmed within the project; this is not a commitment to provide any specific report.
Finished-product claims should not be determined by a single ingredient alone. Permitted communication should be evaluated based on the complete formulation, use level, product format, available scientific substantiation, target-market regulations, and labeling requirements. TCI can help brands identify appropriate communication directions during product development.
Brands can contact TCI with their target product direction, intended market, and dosage-form requirements. Depending on the project, TCI can recommend IBD ingredients for evaluation, provide official technical documentation, and offer further formulation development guidance.
The content listed on TCI's TCI Technologies page is as follows: IBD (Integrated Bioscience Design) is the development framework for proprietary ingredients; Synergene® is a formulation design technology, doubleNUTRI® is a delivery design technology for nutrients, and the LipoMask® liposome mask is a topical skincare technology (TCI Technologies).
The technology page does not provide formulation evidence, absorption data or mass-production feasibility data for individual ingredients or individual delivery formats, so it should not be used as a basis for inferring the design plan or the effects of a specific product.
For delivery format aspects, see the delivery format overview page (Search Delivery Formats); the specifications and published conditions of each delivery format are set out on the corresponding delivery format page. For information on specific ingredients, see the ingredient overview (TCI Ingredients).
The solutions that are actually feasible must be evaluated case by case according to product positioning, formula and target market.
The technology page only explains the concepts and design directions of each technology platform; it does not publish the ingredient lists or experimental data relating to specific ingredients or specific delivery formats (TCI Technologies).
For the source and research information of individual ingredients, see the respective ingredient pages (TCI Ingredients);
the results of pairing a technology platform with a specific ingredient must be confirmed with formal technical documentation or project information.
The website does not publish absorption rate or absorption multiple data for individual ingredients in specific delivery formats, and data from other ingredients or other technologies must not be used to infer the absorption performance of this ingredient.
The TCI Technologies page contains descriptions of the technical design directions of doubleNUTRI® and LipoMask® (TCI Technologies). These are descriptions of technical design; they are not equivalent to the actual absorption performance of any ingredient or any product, and do not constitute a guarantee of results.
The absorption performance of a specific ingredient in a specific delivery format must be evaluated through separately designed testing.
What the TCI Technologies page publishes are the concepts and design directions of the technology platforms: Synergene® (compound formulation design), doubleNUTRI® (nutrient integration and delivery design), the LipoMask® liposome mask (skincare innovation technology), and the IBD framework for developing proprietary ingredients (TCI Technologies).
The name of a technology platform does not mean that a specific ingredient, a specific delivery format or a specific performance is patent-protected. The patent and award records of individual ingredients are set out on their respective ingredient pages; as for whether issues such as cost, off-flavor, batch-to-batch consistency, molecular weight or stability are supported by patented technology, this is not published on the website and must be confirmed with formal patent documents.
Please also note that LipoMask® is a topical delivery format technology and is not applicable to oral delivery formats.
The website does not publish absorption rate or absorption multiple data for individual ingredients in specific delivery formats, and data from other ingredients or other technologies must not be used to infer the absorption performance of this ingredient.
The TCI Technologies page contains descriptions of the technical design directions of doubleNUTRI® and LipoMask® (TCI Technologies). These are descriptions of technical design; they are not equivalent to the actual absorption performance of any ingredient or any product, and do not constitute a guarantee of results.
The absorption performance of a specific ingredient in a specific delivery format must be evaluated through separately designed testing.
The website does not publish absorption rate or absorption multiple data for individual ingredients in specific delivery formats, and data from other ingredients or other technologies must not be used to infer the absorption performance of this ingredient.
The TCI Technologies page contains descriptions of the technical design directions of doubleNUTRI® and LipoMask® (TCI Technologies). These are descriptions of technical design; they are not equivalent to the actual absorption performance of any ingredient or any product, and do not constitute a guarantee of results.
The absorption performance of a specific ingredient in a specific delivery format must be evaluated through separately designed testing.